The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Reduction of HIV-1 RNA Levels with Therapy to Suppress Herpes Simplex Virus
Open accessAbstract
BACKGROUND: Epidemiologic data suggest that infection with herpes simplex virus type 2 (HSV-2) is associated with increased genital shedding of human immunodeficiency virus type 1 (HIV-1) RNA and HIV-1 transmissibility. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of HSV suppressive therapy with valacyclovir (at a dose of 500 mg twice daily) in Burkina Faso among women who were seropositive for HIV-1 and HSV-2; all were ineligible for highly active antiretroviral therapy. The patients were followed for 24 weeks (12 weeks before and 12 weeks after randomization). Regression models were used to assess the effect of valacyclovir on the presence and quantity of genital and plasma HIV-1 RNA and genital HSV-2 DNA during treatment, adjusting for baseline values, and to evaluate the effect over time. RESULTS: A total of 140 women were randomly assigned to treatment groups; 136 were included in the analyses. At enrollment, the median CD4 cell count was 446 cells per cubic millimeter, and the mean plasma viral load was 4.44 log10 copies per milliliter. With the use of summary-measures analysis, valacyclovir therapy was found to be associated with a significant decrease in the frequency of genital HIV-1 RNA (odds ratio, 0.41; 95% confidence interval [CI], 0.21 to 0.80) and in the mean quantity of the virus (log(10) copies per milliliter, -0.29; 95% CI, -0.44 to -0.15). However, there was no significant decrease in detection of HIV (risk ratio, 0.93; 95% CI, 0.81 to 1.07). HSV suppressive therapy also reduced the mean plasma HIV-1 RNA level by 0.53 log(10) copy per milliliter (95% CI, -0.72 to -0.35). Repeated-measures analysis showed that these effects became significantly stronger during the 3 months of follow-up. CONCLUSIONS: HSV suppressive therapy significantly reduces genital and plasma HIV-1 RNA levels in dually infected women. This finding may have important implications for HIV control. (ClinicalTrials.gov number, NCT00158509 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
Fauci, A. S. (1988) · Science · doi:10.1126/science.3277274 · Cited by 1,486
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Self-citationAge‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review
Smith, J. S., & Robinson, N. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/343739 · Cited by 885
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M., Paavonen, J., Morrow, R. A., Beutner, K. R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035144 · Cited by 720
Wald, A., & Link, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338231 · Cited by 691
Corey, L., Wald, A., Celum, C. L., & Quinn, T. C. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200404150-00001 · Cited by 558
CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?
Grossman, Z., Meier-Schellersheim, M., Sousa, A. E., Victorino, R. M. M., & Paul, W. E. (2002) · Nature Medicine · doi:10.1038/nm0402-319 · Cited by 450
Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected Men
Schacker, T. (1998) · JAMA · doi:10.1001/jama.280.1.61 · Cited by 309
Mbopi‐Kéou, F., Grésenguet, G., Mayaud, P., Weiss, H. A., Gopal, R., Matta, M., Paul, J., Brown, D. W. G., Hayes, R. J., Mabey, D. C. W., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315836 · Cited by 243
Self-citationRecent observations on HIV type-1 infection in the genital tract of men and women
Coombs, R. W., Reichelderfer, P. S., & Landay, A. L. (2003) · AIDS · doi:10.1097/00002030-200303070-00001 · Cited by 241
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
Cunningham, A. L., Turner, R. R., Miller, A. C., Para, M. F., & Merigan, T. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111678 · Cited by 239
The Impact of Active Herpes Simplex Virus Infection on Human Immunodeficiency Virus Load
Mole, L., Ripich, S., Margolis, D., & Holodniy, M. (1997) · The Journal of Infectious Diseases · doi:10.1086/517297 · Cited by 237
Rouet, F., Ekouevi, D. K., Chaix, M.-L., Burgard, M., Inwoley, A., Tony, T. D., Danel, C., Anglaret, X., Leroy, V., Msellati, P., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2709-2717.2005 · Cited by 234
Mosca, J. D., Bednarik, D. P., Raj, N. B., Rosen, C. A., Sodroski, J. G., Haseltine, W. A., Hayward, G. S., & Pitha, P. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7408 · Cited by 233
Determinants of HIV-1 shedding in the genital tract of women
Kovacs, A., Wasserman, S. S., Burns, D., Wright, D. J., Cohn, J., Landay, A., Weber, K., Cohen, M., Levine, A., Minkoff, H., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06653-3 · Cited by 233
Schacker, T., Zeh, J., Hu, H., Shaughnessy, M., & Corey, L. (2002) · The Journal of Infectious Diseases · doi:10.1086/345771 · Cited by 196
Epidemiology of genital herpes simplex virus infection in developed countries.
Malkin, J. (2004) · PubMed · Cited by 149
Association between cervical shedding of herpes simplex virus and HIV-1
McClelland, R. S., Wang, C. C., Overbaugh, J. M., Richardson, B. A., Corey, L., Ashley, R. L., Mandaliya, K. N., Ndinya‐Achola, J. O., Bwayo, J. J., & Kreiss, J. K. (2002) · AIDS · doi:10.1097/00002030-200212060-00007 · Cited by 140
Koelle, D. M., Liu, Z., McClurkan, C. M., Topp, M. S., Riddell, S. R., Pamer, E. G., Johnson, A. S., Wald, A., & Corey, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15537 · Cited by 137
Activation of Human Immunodeficiency Virus by Herpes Simplex Virus
Golden, M. P., Kim, S., Hammer, S. M., Ladd, E. A., Schaffer, P. A., DeLuca, N., & Albrecht, M. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.3.494 · Cited by 124
The interaction between herpes simplex virus and human immunodeficiency virus.
Celum, C. (2004) · PubMed · Cited by 113
Dyck, E. V., Buvé, A., Weiss, H. A., Glynn, J. R., Brown, D., Deken, B. D., Parry, J. V., & Hayes, R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.2961-2965.2004 · Cited by 102
Self-citationTransactivation of the HIV-1 LTR by HSV-1 immediate-early genes
Margolis, D. M., Rabson, A. B., Straus, S. E., et al. (1992) · Virology · doi:10.1016/0042-6822(92)90048-t · Cited by 94
Philpott, S. M., Burger, H., Tsoukas, C. M., Foley, B. T., Anastos, K., Ramirez, C. M., & Weiser, B. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.353-363.2005 · Cited by 92
Ouédraogo, A., Nagot, N., Vergne, L., et al. (2006) · AIDS · doi:10.1097/qad.0b013e328010238d · Cited by 89
Self-citationCelum, C., Robinson, N. J., & Cohen, M. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/425272 · Cited by 81
LeGoff, J., Bouhlal, H., Grésenguet, G., Weiss, H. A., Khonde, N., Hocini, H., Désiré, N., Si‐Mohamed, A., Longo, J. D. D., Chemin, C., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.423-432.2006 · Cited by 62
Self-citationBaeten, J. M., McClelland, R. S., Corey, L., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/383049 · Cited by 58
Nagot, N., Ouédraogo, A., Ouangré, A., et al. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000152399.54648.b9 · Cited by 43
Self-citationCowan, F. M., Pascoe, S. J. S., Barlow, K. L., Langhaug, L. F., Jaffar, S. S., Hargrove, J. W., Robinson, N. J., Latif, A. S., Bassett, M. T., Wilson, D. H., et al. (2006) · AIDS · doi:10.1097/01.aids.0000198086.39831.4a · Cited by 41
Cited by
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904849 · Cited by 524
Adolescent girls and young women: key populations for HIV epidemic control
Dellar, R. C., Dlamini, S., & Karim, Q. A. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.2.19408 · Cited by 489
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53488-0.00011-0 · Cited by 474
Celum, C., Wald, A., Hughes, J., Sanchez, J., Reid, S., Delany-Moretlwe, S., Cowan, F., Casapia, M., Ortiz, A., Fuchs, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60920-4 · Cited by 449
Super-spreaders in infectious diseases
Stein, R. A. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.06.020 · Cited by 388
Metadata
- Authors
- Nagot, N., Ouédraogo, A., Foulongne, V., Konaté, I., Weiss, H. A., Vergne, L., Defer, M.-C., Djagbaré, D., Sanon, A., Andonaba, J.-B., Becquart, P., Segondy, M., Vallo, R., Sawadogo, A., Van de Perre, P., & Mayaud, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-02-22
- Volume
- 356
- Issue
- 8
- Pages
- 790-799
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2038075095
- Cited by
- 389
- References
- 33
- FWCI
- 40.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.